Quantitative analysis of large numbers of human tumours using panels of antibodies has allowed a variety of expression phenotypes to be classified, including post-translational modifications and examination of the expression of p53-induced gene products (Nenutil et al, 2005). This evidence concerns the gene TP53 and neoplasm.